Oxford BioMedica PLC (OXB) — Cash Flow-to-Debt Ratio
Oxford BioMedica PLC (OXB) has a Cash Flow-to-Debt Ratio of 0.01x as of June 2025, meaning its operating cash flow of GBX2.35 Million could theoretically repay 0% of its total liabilities (GBX183.59 Million) in one year. Explore Oxford BioMedica PLC (OXB) investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Oxford BioMedica PLC Cash Flow-to-Debt Ratio (1996–2024)
Historical debt coverage capacity for Oxford BioMedica PLC across 28 annual periods. Also explore balance sheet size of Oxford BioMedica PLC for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Oxford BioMedica PLC (1996–2024)
Year-by-year debt coverage analysis for Oxford BioMedica PLC. For market capitalisation and broader financial context, see Oxford BioMedica PLC (OXB) total market value.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.30x | GBX-50.63 Million | GBX171.16 Million | ▼ -81.0% |
| 2023 | -0.16x | GBX-28.52 Million | GBX174.51 Million | ▼ -190.2% |
| 2022 | -0.06x | GBX-12.62 Million | GBX223.99 Million | ▼ -111.0% |
| 2021 | 0.51x | GBX25.45 Million | GBX49.89 Million | ▲ +1065.5% |
| 2020 | 0.04x | GBX3.12 Million | GBX71.18 Million | ▲ +159.0% |
| 2019 | -0.07x | GBX-3.51 Million | GBX47.30 Million | ▼ -144.8% |
| 2018 | 0.17x | GBX12.87 Million | GBX77.66 Million | ▲ +229.6% |
| 2017 | 0.05x | GBX2.98 Million | GBX59.26 Million | ▲ +143.6% |
| 2016 | -0.12x | GBX-5.11 Million | GBX44.33 Million | ▲ +64.0% |
| 2015 | -0.32x | GBX-13.12 Million | GBX40.96 Million | ▲ +42.8% |
| 2014 | -0.56x | GBX-6.03 Million | GBX10.77 Million | ▲ +75.9% |
| 2013 | -2.32x | GBX-11.02 Million | GBX4.75 Million | ▼ -10.6% |
| 2012 | -2.10x | GBX-10.04 Million | GBX4.78 Million | ▼ -34.6% |
| 2011 | -1.56x | GBX-12.98 Million | GBX8.32 Million | ▼ -70.7% |
| 2010 | -0.91x | GBX-12.83 Million | GBX14.04 Million | ▼ -1007.1% |
| 2009 | 0.10x | GBX2.31 Million | GBX22.97 Million | ▲ +111.0% |
| 2008 | -0.91x | GBX-18.13 Million | GBX19.85 Million | ▼ -664.5% |
| 2007 | 0.16x | GBX4.73 Million | GBX29.23 Million | ▲ +105.1% |
| 2006 | -3.14x | GBX-17.13 Million | GBX5.45 Million | ▲ +0.5% |
| 2005 | -3.16x | GBX-8.34 Million | GBX2.64 Million | ▲ +32.8% |
| 2004 | -4.70x | GBX-10.37 Million | GBX2.21 Million | ▲ +26.4% |
| 2003 | -6.38x | GBX-9.58 Million | GBX1.50 Million | ▲ +21.9% |
| 2002 | -8.17x | GBX-10.30 Million | GBX1.26 Million | ▼ -64.4% |
| 2001 | -4.97x | GBX-8.73 Million | GBX1.76 Million | ▼ -36.0% |
| 2000 | -3.66x | GBX-4.90 Million | GBX1.34 Million | ▲ +18.2% |
| 1999 | -4.47x | GBX-3.58 Million | GBX801.00K | ▲ +36.3% |
| 1998 | -7.03x | GBX-3.37 Million | GBX480.00K | ▼ -3588.1% |
| 1996 | -0.19x | GBX-24.00K | GBX126.00K | — |